Changes to the project registry of swissethics

24.09.2019

Since 2016, swissethics has regularly published clinical trials and research projects that have been approved by the competent ethics committees in Switzerland. The focus was on "ongoing" clinical trials and research projects (RoPS, Registry of ongoing projects in Switzerland).

From now on, all clinical trials/projects will be published. Consequently, those that have already been completed can also be found in the register. Thus, the registry has been renamed RAPS: Registry of All Projects in Switzerland

Updated Guidance for providers of courses on Research Ethics and GCP: new including GCP Refresher courses

06.08.2019

Since 1 January 2014, GCP course providers can have their GCP courses for investigators and sponsor-investigators in Switzerland recognised by swissethics.

Position paper of swissethics on how to manage incidental findings in medical research

06.08.2019

Im Rahmen der Humanforschung gibt es durch Diagnostik und Untersuchungen in einem nicht unerheblichen Prozentsatz im Rahmen von klinischen Studien und Projekten Zufallsbefunde.

Important remarks on the information on the "Temporary authorisation to use medicinal products in accordance with Article 9b paragraph 1 HMG" of 13.3.2019

10.04.2019

The information published by swissethics on 13.3.2019 is aimed at pharmaceutical companies, i.e. sponsors who can apply for a temporary authorisation for their drug under certain conditions.

Temporary authorisation to use medicinal products in accordance with Article 9b para. 1 TPA

13.03.2019

The total revision of the Ordinance on the Authorisation of Medicinal Products (AMBV) entered into force on 1st January 2019.